UK pharma major AstraZeneca (LSE: AZN) is set to present data from more than 80 studies at the 2025 American Society of ...

Privately-held US genome-scale drug discovery company Orionis Biosciences has announced a second multi-year collaboration ...

Swiss biosimilars specialist Sandoz (SIX: SDZ) has launched what it says is the first autoinjector presentation of a biosimilar to Stelara (ustekinumab) in Europe, bolstering its presence in the ...

Merck KGaA (MRK: DE) plans to move its investigational lupus drug enpatoran into late-stage development, after new Phase II data showed clinically meaningful improvement in skin manifestations of the ...

The share of generics in the Russian pharmaceutical market is steadily growing despite the efforts of the local state to ...

The US Food and Drug Administration (FDA) is set to sharply restrict vaccine availability to millions of Americans without a ...

Anglo-Swedish pharma major AstraZeneca reports that it will have a historic presence at this year’s American Society of ...

US biotech Moderna (Nasdaq: MRNA) today announced that in consultation with the US Food and Drug Administration (FDA), the ...

Earlier this month, the US Department of Health and Human Services (HHS) said it would require all future vaccines to undergo ...

The Dementia Discovery Fund (DDF)—managed by healthcare fund manager SV Health Investors—has announced the final closing of ...

Pharmasyntez, one of Russia’s leading drugmakers, plans a significant expansion of its portfolio of innovative drugs in the ...

Swiss reproductive and women’s health medicines specialist ReproNovo today announced the successful closing of a $65 million ...